Vol. 52 | No. 2 | July-December 2024Back

Open Access

Clip It or Let It: The Efficacy of Mitral Valve Transcatheter Edge-to-Edge Repair Versus Conservative Treatment in Reducing Mortality Among Patients With Ischemic Mitral Regurgitation

Giovanni A. Vista, Marivic V. Vestal, Von Jerick B. Tenorio
Nov 2024 DOI 10.69944/pjc.67f06d54cc

More Info

Giovanni A. Vista, MD | Marivic V. Vestal, MD | Von Jerick B. Tenorio, MD

Department of Adult Cardiology, Perpetual Succour Hospital - Cebu Heart Institute, Gorordo Avenue, Cebu City

Correspondence:
Giovanni A. Vista, MD
E-mail address: giovistalano124@gmail.com

References
  1. Vahanian A, Beyersdorf F, Praz F, et al, ESC/EACTS Scientific Document Group 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022;43(7):561–632. doi:10.1093/eurheartj/ehab395.
  2. Varma PK, Krishna N, Jose RL, Madkaiker AN. Ischemic mitral regurgitation. Ann Card Anaesth 2017;20(4):432–439. https://doi.org/10.4103/aca.ACA_58_17.
  3. Hickey MS, Smith LR, Muhlbaier LH, et al. Current prognosis of ischemic mitral regurgitation. Implications for future management. Circulation 1988;78(3 pt 2):I51–I59.
  4. Godley RW, Wann LS, Rogers EW, Feigenbaum H, Weyman AE. Incomplete mitral leaflet closure in patients with papillary muscle dysfunction. Circulation 1981;63(3):565–571. doi:10.1161/01.cir.63.3.565.
  5. Fehrenbacher G, Schmidt DH, Bommer WJ. Evaluation of transient mitral regurgitation in coronary artery disease. Am J Cardiol 1991;68(9):868–873. doi:10.1016/0002-9149(91)90401-6.
  6. Hennessey B, Sabatovicz N Jr, del Trigo M. Acute ischaemic mitral valve regurgitation. J Clin Med 2022;11(19):5526. doi:10.3390/jcm11195526.
  7. Lamas GA, Mitchell GF, Flaker GC, et al. Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. Circulation 1997;96(3):827–833. doi:10.1161/01.cir.96.3.827.
  8. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001;103(13):1759–1764. doi:10.1161/01.cir.103.13.1759.
  9. Goldstein D, Moskowitz AJ, Gelijns AC, et al, CTSN. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med 2016;374(4):344–353. doi:10.1056/NEJMoa1512913.
  10. Ypenburg C, Lancellotti P, Tops LF, et al. Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy. Eur Heart J 2008;29(6):757–765. doi:10.1093/eurheartj/ehn063.
  11. Barzilai B, Gessler C Jr, Pérez JE, Schaab C, Jaffe AS. Significance of Doppler-detected mitral regurgitation in acute myocardial infarction. Am J Cardiol 1988;61(4):220–223. doi:10.1016/0002-9149(88)90919-8.
  12. Daimon M, Shiota T, Gillinov AM, et al. Percutaneous mitral valve repair for chronic ischemic mitral regurgitation: a real-time three-dimensional echocardiographic study in an ovine model. Circulation 2005;111(17):2183–2189. doi:10.1161/01.CIR.0000163547.03188.AC.
  13. Obadia JF, Messika-Zeitoun D, Leurent G, et al, MITRA-FR Investigators. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med 2018;379(24):2297–2306. doi:10.1056/NEJMoa1805374.
  14. Stone GW, Lindenfeld J, Abraham WT, et al, COAPT Investigators. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 2018;379(24):2307–2318. doi:10.1056/NEJMoa1806640.
  15. Velazquez EJ, Samad Z, Al-Khalidi HR, et al. The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: a propensity-matched comparison. Am Heart J 2015;170(5):1050.e3–1059.e3. doi:10.1016/j.ahj.2015.08.004.
  16. Asgar AW, Khairy P, Guertin MC, et al. Clinical outcomes and economic impact of transcatheter mitral leaflet repair in heart failure patients. J Med Econ 2017;20(1):82–90. doi:10.1080/13696998.2016.1227828.
  17. Armeni P, Boscolo PR, Tarricone R, et al. Real-world cost effectiveness of MitraClip combined with medical therapy versus medical therapy alone in patients with moderate or severe mitral regurgitation. Int J Cardiol 2016;209:153–160. doi:10.1016/j.ijcard.2016.01.212.
  18. Giannini C, Fiorelli F, de Carlo M, et al. Comparison of percutaneous mitral valve repair versus conservative treatment in severe functional mitral regurgitation. Am J Cardiol 2016;117(2):271–277. doi:10.1016/j.amjcard.2015.10.044.
  19. Kortlandt F, Velu J, Schurer R, et al. Survival after MitraClip treatment compared to surgical and conservative treatment for high-surgical-risk patients With mitral regurgitation. Circ Cardiovasc Interv 2018;11(6):e005985. doi:10.1161/CIRCINTERVENTIONS.117.005985.
  20. Piérard LA, Carabello BA. Ischaemic mitral regurgitation: pathophysiology, outcomes and the conundrum of treatment. Eur Heart J 2010;31(24):2996–3005. doi:10.1093/eurheartj/ehq411.
  21. Serri K, Bouchard D, Demers P, et al. Is a good perioperative echocardiographic result predictive of durability in ischemic mitral valve repair? J Thorac Cardiovasc Surgery 2006;131(3):565.e2–573.e2. doi:10.1016/j.jtcvs.2005.09.037.
  22. Buzzatti N, de Bonis M, Denti P, et al. What is a “good” result after transcatheter mitral repair? Impact of 2+ residual mitral regurgitation. J Thorac Cardiovasc Surg 2016;151(1):88–96. doi:10.1016/j.jtcvs.2015.09.099.
License

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.